Text Size

Binge Eating Disorder Treatment Study

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2011 by Ottawa Hospital Research Institute.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Ottawa Hospital Research Institute
ClinicalTrials.gov Identifier:
NCT00848367
First received: February 19, 2009
Last updated: June 13, 2011
Last verified: June 2011
History of Changes
  Purpose

The main objective of the proposed study is to determine whether the effectiveness of a group therapy treatment for Binge Eating Disorder (BED) is improved and attrition reduced by optimally matching women with BED who have high attachment anxiety to Group Psychodynamic Interpersonal Psychotherapy (GPIP). This study represents the next phase in a program of research stemming from a previously conducted randomized controlled trial (RCT).


Condition Intervention
Binge Eating Disorder
 Behavioral: Group Psychodynamic Interpersonal Therapy

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Treatment
Official Title: Optimizing Outcomes for Binge Eating, Depression and Weight Loss for Obese Women With Binge Eating Disorder by Matching to Group Psychological Treatments Based on Level of Attachment Anxiety

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Ottawa Hospital Research Institute:

Primary Outcome Measures:
  • Frequency of binge eating in the Past 28 days [ Time Frame: Pre and Post treatment, 6 months and 1 year ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Earlier response to treatment including lowered BMI, a greater reduction in depression, and more positive change in reported quality of life [ Time Frame: Pre and Post treatment, 6 months and 1 year ] [ Designated as safety issue: No ]

Estimated Enrollment: 120
Study Start Date: April 2007
Estimated Study Completion Date: December 2011
Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
Intervention Details:
    Behavioral: Group Psychodynamic Interpersonal Therapy
    16 weeks of group therapy for patients with Binge Eating Disorder, matching them by attachment anxiety dimensions in order to enhance the impact of the therapy. It is hypothesized that by optimally matching patients to groups, they will have better clinical and health outcomes.
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Overweight Women 18 years of age or older who binge eat at least twice per week for the past month.

Exclusion Criteria:

  • unable speak English
  • history of an eating disorder other than Binge Eating Disorder
  • concurrent DSM-IV diagnosis of bipolar disorder, psychosis, drug or alcohol problem
  • pregnant or planning on becoming pregnant within the next year
  • are currently or plan to become enrolled in a weight loss program within the next year
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00848367

Locations
Canada, Ontario
Regional Centre for the Treatment of Eating Disorders- Ottawa Hospital-General Campus
Ottawa, Ontario, Canada, K2J3J4
Sponsors and Collaborators
Ottawa Hospital Research Institute
Investigators
Principal Investigator: Giorgio Tasca, Ph.D.C.Psych University of Ottawa, Ottawa Hospital-General Campus
  More Information

No publications provided

Responsible Party: George Tasca, Ottawa Health Research Institute
ClinicalTrials.gov Identifier: NCT00848367     History of Changes
Other Study ID Numbers: OHREB 2007254-01H
Study First Received: February 19, 2009
Last Updated: June 13, 2011
Health Authority: Canada: Canadian Institutes of Health Research

Additional relevant MeSH terms:
Bulimia
Binge-Eating Disorder
Eating Disorders
Hyperphagia
 Signs and Symptoms, Digestive
Signs and Symptoms
Mental Disorders

ClinicalTrials.gov processed this record on June 17, 2013